Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery

British Journal of Anaesthesia

Volumn 113, Issue 6, 2014, Pages 970-976

  Ranucci, M ^a   Colella, D ^b   Baryshnikova, E ^a   Di Dedda, U ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

blood, loss; blood, platelets; surgery, cardiovascular

Indexed keywords

ANTITHROMBOCYTIC AGENT; P2RY12 PROTEIN, HUMAN; PROTEINASE ACTIVATED RECEPTOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR; THROMBIN RECEPTOR;

AGED; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD CLOTTING PARAMETERS; CHEMICALLY INDUCED; FEMALE; HEART SURGERY; HUMAN; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE AGGREGATION;

AGED; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PROTEINASE-ACTIVATED; RECEPTORS, PURINERGIC P2Y12; RECEPTORS, THROMBIN; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84925225538     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu315     Document Type: Article

References (21)

1. Pickard, AS, Becker, RC, Schumock, GT, Frye, CB, Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy 28 (2008), 376–392.
2. Purkayastha, S, Athanasiou, T, Malinovski, V, et al. Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis. Heart 92 (2006), 531–532.
3. Ferraris, VA, Ferraris, SP, Saha, SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83 (2007), S27–S86.
4. Fitchett, D, Eikelboom, J, Fremes, S, et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol 25 (2009), 683–689.
5. Ferraris, VA, Brown, JR, Despotis, GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91 (2011), 944–982.
6. Ferraris, VA, Saha, SP, Oestreich, JH, et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 94 (2012), 1761–1781.
7. Ranucci, M, Baryshnikova, E, Soro, G, Ballotta, A, De Benedetti, D, Conti, D, Surgical and Clinical Outcome Research (SCORE) Group, Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 91 (2011), 123–129.
8. Di Dedda, U, Ranucci, M, Baryshnikova, E, Castelvecchio, S, Surgical and Clinical Outcome Research (SCORE) Group, Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients. Eur J Cardiothorac Surg 45 (2014), 165–170.
9. Edmunds, LH, Colman, RW, Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82 (2006), 2315–2322.
10. Tello-Montoliu, A, Tomasello, SD, Ueno, M, Angiolillo, DJ, Antiplatelet therapy: thrombin receptor antagonists. Br J Clin Pharmacol 72 (2011), 658–671.
11. Tantry, US, Bonello, L, Aradi, D, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 62 (2013), 2261–2273.
12. Mahla, E, Suarez, TA, Bliden, KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 5 (2012), 261–269.
13. Dyke, C, Aronson, S, Dietrich, W, et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg, 2013 doi:10.1016/j.jtcvs.2013.10.070.
14. 12 inhibitors. Int J Cardiol 168 (2013), 403–406.
15. Gremmel, T, Calatzis, A, Steiner, S, et al. Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?. Platelets 21 (2010), 515–521.
16. Jakubowski, JA, Payne, CD, Weerakkody, GJ, et al. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects. J Cardiovasc Pharmacol 49 (2007), 167–173.
17. Sibbing, D, Schulz, S, Braun, S, et al. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 8 (2010), 250–256.
18. Tricoci, P, Huang, Z, Held, C, et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med 366 (2012), 20–33.
19. Tanaka, KA, Subramaniam, K, II. Looking into the future of platelet transfusion in the presence of P2Y12 inhibitors. Br J Anaesth 112 (2014), 780–784.
20. Hansson, EC, Shams Hakimi, C, Åström-Olsson, K, et al. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. Br J Anaesth 112 (2014), 570–575.
21. Chackalamannil, S, Wang, Y, Greenlee, WJ, et al. Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J Med Chem 51 (2008), 3061–3064.